Humanigen, Inc. reported earnings results for the fourth quarter ended December 31, 2021. For the fourth quarter, the company reported net loss was USD 33.54 million compared to USD 32.3 million a year ago. Basic loss per share from continuing operations was USD 0.53 compared to USD 0.63 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.0003 USD | +50.00% | +50.00% | -75.00% |
12/04 | Combined Liquidation Plan and Disclosure Statement Filed by Humanigen, Inc. | CI |
08/03 | Final DIP Financing Approved for Humanigen, Inc. | CI |
1st Jan change | Capi. | |
---|---|---|
-75.00% | 23.82T | |
-1.64% | 9.03TCr | |
-1.97% | 3.95TCr | |
-15.47% | 3.17TCr | |
+61.28% | 2.64TCr | |
-22.81% | 1.43TCr | |
-8.82% | 1.29TCr | |
-11.77% | 1.18TCr | |
-45.97% | 1.1TCr | |
+3.30% | 884.67Cr |
- Stock Market
- Equities
- HGENQ Stock
- News Humanigen, Inc.
- Humanigen, Inc. Reports Earnings Results for the Fourth Quarter Ended December 31, 2021